Lung ultrasound score to predict development of acute chest syndrome in children with sickle cell disease

Pedro P.M.G. Vieira, Josefina A.P. Braga, Rodrigo Regacini
{"title":"Lung ultrasound score to predict development of acute chest syndrome in children with sickle cell disease","authors":"Pedro P.M.G. Vieira,&nbsp;Josefina A.P. Braga,&nbsp;Rodrigo Regacini","doi":"10.1016/j.htct.2024.07.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>This study aims to identify lung ultrasound (LUS) findings associated with acute chest syndrome (ACS) at the time of admission and 24–48 h later, to compare these to chest radiography (CXR) findings and to establish a score to predict the development of this pulmonary complication in sickle cell disease (SCD) children</div></div><div><h3>Methods</h3><div>A prospective observational study of SCD children presenting signs or symptoms of ACS evaluated by LUS and CXR at admission and 24–48 h later. A score was conceived to predict the evolution of ACS during hospitalization based on ultrasonographic findings.</div></div><div><h3>Results</h3><div>Seventy-eight children were evaluated; 61 (78.2 %) developed ACS. A score greater than one at admission showed sensitivity, specificity, accuracy, and positive predictive value (PPV) of 75.4 %, 88.2 %, 78.2 %, and 95.8 %, respectively to predict ACS, while only 32 (52.5 %) CXR showed alterations. The development of ACS during hospitalization was unlikely for a score of zero and very likely for a score greater than one at admission. Regarding follow-up exams, a score greater than one showed sensitivity, specificity, accuracy, and PPV of 98.4 %, 76.5 %, 93.6 %, and 92.8 %, respectively to predict the development of ACS. ACS development was very unlikely for a score of zero and very likely for a score greater than zero in the follow-up.</div></div><div><h3>Conclusion</h3><div>LUS is an effective tool to assess risk for the development of ACS in SCD children with clinical suspicion.</div></div>","PeriodicalId":12958,"journal":{"name":"Hematology, Transfusion and Cell Therapy","volume":"46 ","pages":"Pages S239-S245"},"PeriodicalIF":1.6000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hematology, Transfusion and Cell Therapy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2531137924003225","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

This study aims to identify lung ultrasound (LUS) findings associated with acute chest syndrome (ACS) at the time of admission and 24–48 h later, to compare these to chest radiography (CXR) findings and to establish a score to predict the development of this pulmonary complication in sickle cell disease (SCD) children

Methods

A prospective observational study of SCD children presenting signs or symptoms of ACS evaluated by LUS and CXR at admission and 24–48 h later. A score was conceived to predict the evolution of ACS during hospitalization based on ultrasonographic findings.

Results

Seventy-eight children were evaluated; 61 (78.2 %) developed ACS. A score greater than one at admission showed sensitivity, specificity, accuracy, and positive predictive value (PPV) of 75.4 %, 88.2 %, 78.2 %, and 95.8 %, respectively to predict ACS, while only 32 (52.5 %) CXR showed alterations. The development of ACS during hospitalization was unlikely for a score of zero and very likely for a score greater than one at admission. Regarding follow-up exams, a score greater than one showed sensitivity, specificity, accuracy, and PPV of 98.4 %, 76.5 %, 93.6 %, and 92.8 %, respectively to predict the development of ACS. ACS development was very unlikely for a score of zero and very likely for a score greater than zero in the follow-up.

Conclusion

LUS is an effective tool to assess risk for the development of ACS in SCD children with clinical suspicion.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
预测镰状细胞病患儿急性胸部综合征发展的肺部超声波评分。
研究目的本研究旨在确定入院时和 24-48 小时后与急性胸部综合征(ACS)相关的肺部超声波(LUS)检查结果,将这些结果与胸部X光检查(CXR)结果进行比较,并建立预测镰状细胞病(SCD)患儿肺部并发症发展的评分方法:一项前瞻性观察研究,研究对象为入院时和 24-48 小时后出现 ACS 体征或症状的 SCD 患儿,通过 LUS 和 CXR 进行评估。根据超声波检查结果设计了一个评分标准,用于预测住院期间 ACS 的演变情况:结果:78 名儿童接受了评估,其中 61 名(78.2%)患上了 ACS。入院时评分大于 1 分的患儿预测 ACS 的敏感性、特异性、准确性和阳性预测值(PPV)分别为 75.4%、88.2%、78.2% 和 95.8%,而只有 32 名患儿(52.5%)的 CXR 出现了变化。如果入院时的评分为零,则在住院期间发生 ACS 的可能性不大;如果评分大于 1,则发生 ACS 的可能性很大。在随访检查中,得分大于 1 的患者预测发生 ACS 的敏感性、特异性、准确性和 PPV 分别为 98.4%、76.5%、93.6% 和 92.8%。在随访中,得分为零的患者发生 ACS 的可能性很小,得分大于零的患者发生 ACS 的可能性很大:结论:LUS 是评估临床可疑 SCD 儿童发生 ACS 风险的有效工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.40
自引率
4.80%
发文量
1419
审稿时长
30 weeks
期刊最新文献
Functional capacity in sickle cell disease: A pilot study with 1-minute sit-to-stand test Acute fibrinous and organizing pneumonia after bone marrow transplantation, an underrecognized, severe condition Comment on “Risk factors associated with the use of red blood cells in elective cardiac surgeries” Hypoxic conditions confer chemoresistance to crizotinib but not to imatinib in chronic myeloid leukemia cells Comment on clinical characteristics and outcomes of non-tuberculous mycobacterial pulmonary infections after hematopoietic stem cell transplantation: A retrospective cohort study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1